{"nct_id":"NCT01780935","title":"Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration","status":"COMPLETED","status_verified_date":"2017-07","start_date":"2013-06-03","start_date_type":"ACTUAL","primary_completion_date":"2015-07-09","primary_completion_date_type":"ACTUAL","completion_date":"2015-07-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}